Evidence map›Paper›PMID 36761894›Full record

ArticleFrontiers in cellular and infection microbiology2023

Identification of novel

Ramin Mazhari, Eizo Takashima, Rhea J Longley, Shazia Ruybal-Pesantez, Michael T White, Bernard N Kanoi, Hikaru Nagaoka, Benson Kiniboro, Peter Siba, Takafumi Tsuboi and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Vaccination withScience translational medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Ramin MazhariPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Eizo TakashimaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Rhea J LongleyPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Shazia Ruybal-PesantezPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Michael T WhiteInstitut Pasteur, Université de Paris Cité, G5 Épidémiologie et Analyse des Maladies Infectieuses, Département de Santé Globale, Paris, France.
Bernard N KanoiCentre for Research in Infectious Diseases, Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
Hikaru NagaokaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Benson KiniboroVector Borne Disease Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Peter SibaVector Borne Disease Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Takafumi TsuboiDivision of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Ivo MuellerPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Ehime University · JPWalter and Eliza Hall Institute of Medical Research · AUPapua New Guinea Institute of Medical Research · PGMount Kenya University · KEUniversité Paris Cité · FRUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As progress towards malaria elimination continues, the challenge posed by the parasite species

Indexed as

Malaria, FalciparumMalaria, VivaxAntibodies, ProtozoanChildHumansPlasmodium falciparumPlasmodium vivaxProtozoan ProteinsAntibodies, ProtozoanProtozoan Proteinsantibodymalarianaturally acquired immunityPlasmodium vivaxprotective immunityvaccine

Identifiers

PMID36761894
PMCPMC9905245
OpenAlexW4317910536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.